common.study.topics.clinical

Medication Trial for Cervical Osmotic Dilators Placement

common.study.values.description

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D&E) procedures.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Mifepristone 200 MG

Ingestion of study medication vs placebo

Drug - Placebo Oral Tablet

Ingestion of study medication vs placebo

participant.views.study.view.additional

participant.views.study.view.scientific-title

Cervical Preparation With Mifepristone Prior to Osmotic Dilators: A Randomized, Double-blind, Placebo-controlled Pilot Study

common.study.values.clinical-trial-id

NCT03714880

participant.views.study.view.id

av2jma